NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 7.19% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.18% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 7.09% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.85% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 6.53% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 3.74% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.63% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.57% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.54% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 3.53% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.49% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.45% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.42% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.33% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.26% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.28% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 2.24% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 1.92% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.67% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.57% |